Charles S. Ryan - Sep 1, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
President
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Charles S. Ryan, Ph.D.
Stock symbol
QNCX
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
4
Date filed
9/6/2023, 05:43 PM
Next filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Employee Stock Option (right to buy) Award $0 +545K $0.00 545K Sep 1, 2023 Common Stock 545K $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest one year after the date of the grant of September 1, 2023 and the remaining shares will vest in equal monthly installments over the following three years thereafter.